Hypertension
Hypertension, or high blood pressure, is a common, serious, and often symptomless condition that can remain dangerously unrecognized for years. Diet modification and pharmacologic interventions to lower blood pressure can affect existing cardiometabolic concerns such as kidney disease and diabetes, so clinicians must be aware of the guidelines in these populations before implementing care.
News Digest
The latest industry news, CMHC Pulse Blogs and Cardiometabolic Chronicle articles related to hypertension.
Endocrine-Metabolic Consequences of Chronic Maternal Hypertension
Maternal hypertension and hypertensive disorders during pregnancy have been proven to significantly increase the risk of perinatal health complications in both mothers and their offspring.
Racial Inequities in Hypertension Treatment IntensificationÂ
Despite experiencing an increased risk for hypertension, Black patients often constitute a small proportion of clinical trial participants leading to a lack of data supporting
Black History Month: Hypertension in African American Adults
As results of the REGARDS study indicate, African American patients are more likely to be aware of having hypertension, more likely to be undergoing treatment,
Optimal Blood Pressure Guidelines for CAD Prevention in T1D Patients
Hypertension is a major risk factor for cardiometabolic disease and is common among the American population with nearly 1 in 3 adults suffering from high
New Guidelines for High Blood Pressure
According to a joint statement issued Monday by the American Heart Association and the American College of Cardiology, nearly half of all adult Americans will
Increases in Pediatric Hypertension
More children and teens are likely to be categorized as having abnormal blood pressure during their annual wellness visits, based on new recommendations released this week by
Day 4 Nightly News: 18th Annual CMHC
On Saturday, Oct. 21, 2023, Cardiometabolic Health Congress (CMHC) celebrated the final day of its 18th Annual Conference, Social Determinants and Digital Advances in Cardiorenal
Day 3 Nightly News: 18th Annual CMHC
The third day of Social Determinants and Digital Advances in Cardiorenal Metabolic Health, the 18th Annual Cardiometabolic Health Congress (CMHC), delivered insights on selecting and
Day 2 Nightly News: 18th Annual CMHC
The cardiorenal metabolic education continued on Thursday, Oct. 19, 2023, when the 18th Annual Cardiometabolic Health Congress (CMHC) launched its second day of sessions at
Day 1 Preconference Nightly News: 18th Annual CMHC
On Wednesday, Oct. 18, 2023, Cardiometabolic Health Congress (CMHC) returned to the Boston Park Plaza for the 18th Annual Conference, Social Determinants and Digital Advances
Baxdrostat for Treatment-Resistant Hypertension
Investigators reported that baxdrostat at several dose levels reduced plasma aldosterone levels but not cortisol levels in results from the recent BrigHTN study ClinicalTrials gov
Expert Highlights and Perspectives
A cache of recorded faculty presentations addressing the diagnosis, clinical management, treatment, and emerging strategies related to hypertension.
Emerging Therapies for Resistant Hypertension
Cardiometabolic Health Congress co-chair George L. Bakris, MD, provides a brief overview of the evolving landscape of emerging treatment options for resistant hypertension. (Recorded on February 14, 2023)
Hypertension & Healthy Lifestyle in Older Adults
Blood pressure control and living a healthy lifestyle are key in the management of cardiometabolic risk, however, they can be challenging to optimize in older adults. In this interview, CMHC co-chair Robert Eckel, MD interviews Drs. Dennis Villareal and Dena Rifkin to share some additional perspectives on how to better manage hypertension and encourage healthy lifestyle modifications in this populatio. (Recorded October 19, 2022)
Recap of Important Updates in Cardiometabolic Medicine in 2022
CMHC co-chairs Drs. Robert Eckel, George Bakris, Christie Ballantyne and CMHC Senior Planning Committee members Drs Deepak Bhatt and Keith Ferdinand recap important highlights of key trials and developments in cardiometabolic medicine in 2022, including obesity, hypertension, chronic kidney disease, heart failure, dyslipidemia, atherothrombosis and more. (Recorded October 20, 2022)
Resources
A collection of resources related to hypertension for both patients and provider education and connection.
- Self-Measured Blood Pressure Monitoring at Home: A Joint Statement from the American Heart Association and American Medical Association
- US Guidelines - Hypertension Management
- European Guidelines for Hypertension
- Validatebp.org – US Blood Pressure Validated Device Listing
- American Heart Association - Blood Pressure Toolkit
- Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How? A Scientific Statement from the American Heart Association
- Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement from the American Heart Association
- Novel Therapies on The Horizon of Hypertension Management
- 2023 European Consensus Statement on Renal Denervation for Hypertension
Drug Pipelines
ASO = antisense oligonucleotide; RNAi = RNA interference
Coming Soon
CME Activities
Available courses, certification information, and the latest educational opportunities for practitioners interested in beginning or continuing their careers in a cardiometabolic subspecialty with emphasis on hypertension.
